Gilead Sciences (GILD) Return on Invested Capital [ROIC] (2009 - 2026)
Gilead Sciences' Return on Invested Capital [ROIC] came in at -5.97% for Q2 2026, down 21.90 percentage points from 15.93% a year earlier and down 25.08 percentage points from the prior quarter.
Gilead Sciences (GILD) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences' Return on Invested Capital [ROIC] was 18.60%, up 16.14 percentage points from FY2024.
- Return on Invested Capital [ROIC] carries a five-year change of +18.16 percentage points (FY2020 to FY2025).
- Going back by year, Return on Invested Capital [ROIC] was 2.46% in FY2024 (-10.75 pp), 13.21% in FY2023 (+0.99 pp), 12.22% in FY2022 (-3.04 pp) and 15.26% in FY2021 (+14.81 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Invested Capital [ROIC] in data going back to Q3 2009.
- Year-over-year, Return on Invested Capital [ROIC] increased in five of the last eight quarters, with an average year-over-year change of +2.21 percentage points.
- The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q3 2025 (a gain of 17.64 percentage points), and the weakest in Q2 2026 (a drop of 21.90 percentage points).
- Business Quant data shows GILD's Return on Invested Capital [ROIC] at 19.11% (Q1 2026), 18.50% (Q4 2025) and 18.91% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.97% |
| Mar 31, 2026 | 19.11% |
| Dec 31, 2025 | 18.50% |
| Sep 30, 2025 | 18.91% |
| Jun 30, 2025 | 15.93% |
| Mar 31, 2025 | 15.97% |
| Dec 31, 2024 | 2.63% |
| Sep 30, 2024 | 1.27% |
| Jun 30, 2024 | 4.08% |
| Mar 31, 2024 | 1.48% |
| Dec 31, 2023 | 13.10% |
| Sep 30, 2023 | 14.22% |
| Jun 30, 2023 | 13.56% |
| Mar 31, 2023 | 14.55% |
| Dec 31, 2022 | 12.42% |
| Sep 30, 2022 | 9.43% |
| Jun 30, 2022 | 11.22% |
| Mar 31, 2022 | 11.79% |
| Dec 31, 2021 | 15.33% |
| Sep 30, 2021 | 18.54% |
Gilead Sciences Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();